<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27834072</article-id>
      <article-id pub-id-type="pmc">5107624</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2017.37.1.77</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case of Chronic Myeloid Leukemia With Rare Variant <italic>ETV6/ABL1</italic> Rearrangement</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Soo In</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Mi-Ae</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>Woo Joon</given-names>
          </name>
          <degrees>M.T.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>Byung Ryul</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Yong-Wha</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Hee Bong</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Dae-Sik</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>You Kyoung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, Division of Hematology &amp; Oncology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: You Kyoung Lee. Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Wonmi-gu, Bucheon 14584, Korea. Tel: +82-32-621-5941, Fax: +82-32-621-5944, <email>cecilia@schmc.ac.kr</email></corresp>
        <fn id="FN1" fn-type="equal">
          <p><sup>*</sup>These two authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <volume>37</volume>
      <issue>1</issue>
      <fpage>77</fpage>
      <lpage>80</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>09</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <funding-group>
        <award-group>
          <funding-source country="KR">
            <institution-wrap>
              <institution>Soonchunhyang University</institution>
              <institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100002560</institution-id>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>The translocation (9;12)(q34;p13) <italic>ETV6/ABL1</italic> rearrangement is a rare but recurrent chromosomal translocation associated with a variety of hematological malignancies, including CML, atypical CML, AML, and ALL [<xref rid="B1" ref-type="bibr">1</xref>]. The structure of the ETV6/ABL1 oncoprotein is similar to that of BCR/ABL1, and they initiate similar downstream pathways [<xref rid="B2" ref-type="bibr">2</xref>]. There are two <italic>ETV6/ABL1</italic> fusion isoforms: the type A isoform, which fuses <italic>ETV6</italic> exon 4 with <italic>ABL1</italic> exon 2; and the type B isoform, which fuses <italic>ETV6</italic> exon 5 with <italic>ABL1</italic> exon 2 [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. To date, 30 cases of <italic>ETV6/ABL1</italic> fusion have been reported [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>], and only one of these cases resulted in CML with positive <italic>BCR/ABL1</italic> rearrangement [<xref rid="B7" ref-type="bibr">7</xref>]. Herein, we report a rare case of CML with <italic>ETV6/ABL1</italic> rearrangement.</p>
    <p>A 54-yr-old male was admitted with persistent leukocytosis. Complete blood counts showed a white blood cell count of 21.7&#xD7;10<sup>9</sup>/L with 1% blasts, Hb of 126 g/L, and platelet count of 294&#xD7;10<sup>9</sup>/L. Physical examination was unremarkable. Bone marrow (BM) analysis showed typical characteristics of CML (<xref ref-type="fig" rid="F1">Fig. 1A, B</xref>). Chromosomal analysis of the BM cells demonstrated a balanced t(9;12)(q34;p13) translocation, which was not the Philadelphia chromosome (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). FISH analysis with probes for <italic>BCR/ABL1</italic> (Abbott Vysis, Des Plaines, IL, USA detected no fusion signal. However, reverse transcriptase (RT)-PCR analysis of the <italic>BCR/ABL1</italic> fusion transcripts yielded positive results; the reaction product was 700 bp long, indicating positive rearrangement and hence, presence of the P230 chimeric protein at the molecular level (<xref ref-type="fig" rid="F1">Fig. 1D</xref>).</p>
    <p>To visualize the <italic>ETV6/ABL1</italic> fusion signal, we prepared a mixture of two commercially available, locus-specific identifiers: a <italic>BCR/ABL1</italic> dual color, dual fusion translocation probe, and an <italic>ETV6/RUNX1</italic> extra signal dual color translocation probe (Abbott Vysis) (<xref ref-type="fig" rid="F1">Fig. 1E, F</xref>). Metaphase and interphase FISH with the mixed <italic>BCR/ABL1</italic> and <italic>ETV6/RUNX1</italic> probes showed one yellow fusion signal at 9q34, which was derived from a green signal from <italic>ETV6</italic> and a red signal from <italic>ABL1</italic> (<xref ref-type="fig" rid="F1">Fig. 1G, H</xref>). RT-PCR analysis of the <italic>ETV6/ABL1</italic> fusion transcript was positive for the 1,141-bp product, indicating a type B fusion (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). After diagnosis, the patient was transferred to another hospital, and therefore, follow-up BM examination was not possible.</p>
    <p><italic>ETV6/ABL1</italic> rearrangement has been reported to result in enhanced tyrosine kinase activity and neoplastic transformation [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. A total of 13 cases of <italic>ETV6/ABL1</italic>-positive or atypical CML have been reported to date (<xref ref-type="table" rid="T1">Table 1</xref>) [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. Among those cases, including the present case, two were <italic>BCR/ABL1</italic> fusion-positive and 11 were either unknown or negative for the <italic>BCR/ABL1</italic> fusion. Both <italic>BCR/ABL1</italic> fusion-positive cases presented with persistent leukocytosis, eosinophilia, and no splenomegaly. Their pathological findings were consistent with those for CML, but <italic>BCR/ABL1</italic> rearrangement was not confirmed by karyotyping or FISH. Only RT-PCR revealed the rearrangement, and the amplicon size was 504 bp [<xref rid="B7" ref-type="bibr">7</xref>] and 700 bp in the present case, respectively. Marked eosinophilia, which is a common characteristic of the <italic>ETV6/ABL1</italic> translocation [<xref rid="B7" ref-type="bibr">7</xref>], was also predominant. Although the pathogenesis of eosinophilia is not clearly understood, <italic>ETV6</italic> is known to play an active role in the commitment of hematopoietic myeloid precursors to eosinophilic differentiation [<xref rid="B9" ref-type="bibr">9</xref>].</p>
    <p>Rare cases of CML are associated with a <italic>BCR</italic> breakpoint that is considerably more directed towards the 3' end than the major breakpoint cluster region, which encodes a P230 <italic>BCR/ABL1</italic> fusion protein. Our patient had a novel-sized <italic>BCR/ABL1</italic> fusion transcript (700 bp), which is ~140 bp smaller than the typically observed micro <italic>BCR/ABL1</italic> (c3a3) amplicon size of 838 bp, suggesting in-frame deletion of an exon. Although the lack of the Philadelphia chromosome observed by karyotyping and FISH is unusual, it is possible that RT-PCR is more sensitive than cytogenetics or FISH. Unfortunately, Sanger sequencing of the identified novel transcript could not be performed, and 2 weeks later, a repeat RT-PCR analysis of the peripheral blood failed to detect any <italic>BCR/ABL1</italic> fusion transcripts.</p>
    <p>Detection of the <italic>ETV6/ABL1</italic> fusion may help to inform treatment plans for patients with rare hematologic malignancies. In these cases, tyrosine kinase inhibitors can be effective because of the significant overlap between the molecular targets of <italic>ETV6/ABL1</italic> and those of <italic>BCR/ABL1</italic> [<xref rid="B10" ref-type="bibr">10</xref>].</p>
    <p>In conclusion, we identified an <italic>ETV6/ABL1</italic> translocation in a patient with CML, which was confirmed by FISH with combined <italic>BCR/ABL1</italic> and <italic>ETV6/RUNX1</italic> probes, as well as by RT-PCR analysis. This report will contribute to a better understanding of the clinical phenotype and molecular basis of this rare type of <italic>ETV6/ABL1</italic>-positive hematologic malignancy.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by the Soonchunhyang University Research Fund.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Braekeleer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Douet-Guilbert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Le Bris</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Basinko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Braekeleer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ETV6 fusion genes in hematological malignancies: a review</article-title>
          <source>Leuk Res</source>
          <year>2012</year>
          <volume>36</volume>
          <fpage>945</fpage>
          <lpage>961</lpage>
          <pub-id pub-id-type="pmid">22578774</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malinge</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Monni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Penard-Lacronique</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>3589</fpage>
          <lpage>3597</lpage>
          <pub-id pub-id-type="pmid">16434962</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Variant of ETV6/ABL1 gene is associated with leukemia phenotype</article-title>
          <source>Acta Haematol</source>
          <year>2013</year>
          <volume>129</volume>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">23171811</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Million</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Harakawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roumiantsev</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Varticovski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Van Etten</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>4685</fpage>
          <lpage>4695</lpage>
          <pub-id pub-id-type="pmid">15143164</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gancheva</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Virchis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Howard-Reeves</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cross</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Brazma</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review</article-title>
          <source>Mol Cytogenet</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>39</fpage>
          <pub-id pub-id-type="pmid">24053143</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>A cryptic ETV6/ABL1 rearrangement represents a unique fluorescence in situ hybridization signal pattern in a patient with B acute lymphoblastic leukemia</article-title>
          <source>Ann Lab Med</source>
          <year>2014</year>
          <volume>34</volume>
          <fpage>475</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">25368826</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keung</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Beaty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steward</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jackle</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pettnati</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>2002</year>
          <volume>138</volume>
          <fpage>139</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="pmid">12505259</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Braekeleer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Douet-Guilbert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bown</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Berthou</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ABL1 fusion genes in hematological malignancies: a review</article-title>
          <source>Eur J Haematol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>361</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">21435002</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>La Starza</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Trubia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Testoni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ottaviani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Belloni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Crescenzi</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia</article-title>
          <source>Haematologica</source>
          <year>2002</year>
          <volume>87</volume>
          <fpage>789</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="pmid">12161353</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perna</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Abdel-Wahab</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Jhanwar</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Imada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nimer</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition</article-title>
          <source>Haematologica</source>
          <year>2011</year>
          <volume>96</volume>
          <fpage>342</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="pmid">21193423</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Bone marrow (BM) aspiration, biopsy, karyotyping, reverse transcription (RT)-PCR, and FISH analyses of the present case. (A) BM aspiration (Wright-Giemsa stain, &#xD7;400) and (B) BM biopsy (hematoxylin &amp; eosin stain, &#xD7;50) revealed 90% hypercellular marrow with a left-shifted neutrophilic series, an increased number of eosinophilic precursors, and small, hypolobated megakaryocytes. (C) Karyotyping showing t(9;12)(q34;p13); arrows indicate the translocated regions. (D) RT-PCR using <italic>BCR/ABL1</italic> and <italic>ETV6/ABL1</italic> primer pairs, revealing the 700-bp <italic>BCR/ABL1</italic> (lane 1, arrow) and 1,141-bp <italic>ETV6/ABL1</italic> (lane 2, arrow) fusion transcripts; left, 100-bp molecular weight marker ladder. The internal control 911-bp band is shown in lane 2. (E and F) FISH analysis using <italic>BCR/ABL1</italic> or <italic>ETV6/RUNX1</italic> probes, showing no abnormal signal. (G and H) FISH using the mixed <italic>BCR/ABL1</italic> and <italic>ETV6/RUNX1</italic> probes revealing one yellow fusion signal (<italic>ABL1</italic>, red; <italic>ETV6</italic>, green) on 9q34 analyzed in interphase (G) and metaphase (H) cells.</title>
      </caption>
      <graphic xlink:href="alm-37-77-g001"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Summary of patients with CML or atypical CML carrying the <italic>ETV6/ABL1</italic> fusion transcript</title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-37-77-i001"/>
        <table frame="hsides" rules="rows">
          <col width="10%" span="1"/>
          <col width="10%" span="1"/>
          <col width="10%" span="1"/>
          <col width="10%" span="1"/>
          <col width="10%" span="1"/>
          <col width="10%" span="1"/>
          <col width="25%" span="1"/>
          <col width="15%" span="1"/>
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)"/>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Sex/Age (yr)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Splenomagaly</th>
              <th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(218,227,244)">Initial CBC (WBC/Hb/Platelet)*</th>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Eosinophilia</th>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">Karyotype</th>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)"><italic>BCR/ABL1</italic> fusion (isoform)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)"><italic>ETV6/ABL1</italic> fusion isoform</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="right" rowspan="1" colspan="1">NA/49</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="2">NA/NA/NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Type B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">2</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">M/32</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">No</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">29/135/337</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XY,t(12;14)(p12;q11&#x2013;13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Negative</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Type B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="right" rowspan="1" colspan="1">M/59</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="2">27/66/344</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46,XY,del(6)(p21),?t(9;12)(q34;p12)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Type A</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">4</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">M/38</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">77.6/103/90</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XY</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Types A, B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">5</td>
              <td valign="top" align="right" rowspan="1" colspan="1">M/53</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="center" rowspan="1" colspan="2">22/131/378</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46,XY</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Types A, B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">6</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">F/44</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">No</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">37/123/370</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XX,t(9;12)(q34;p13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Positive (P210)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">7</td>
              <td valign="top" align="right" rowspan="1" colspan="1">M/36</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="2">23.8/96/88</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">45,XY,&#x2013;7,t(9;12)(q34;q13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Type B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">8</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">M/72</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">57/98/32</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XY</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">9</td>
              <td valign="top" align="right" rowspan="1" colspan="1">F/24</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="2">98.8/113/261</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46,XX</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Type A</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">10</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">M/79</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">35.2/141/176</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XY</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">11</td>
              <td valign="top" align="right" rowspan="1" colspan="1">M/36</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="2">55/NA/NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46,XY,t(9;12)(q34;p13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
              <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">12</td>
              <td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">F/52</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(238,242,249)">Increased/NA/Increased</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">46,XX,t(9;12)(q34;p13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Types A, B</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Present case</td>
              <td valign="top" align="right" rowspan="1" colspan="1">M/54</td>
              <td valign="top" align="center" rowspan="1" colspan="1">No</td>
              <td valign="top" align="center" rowspan="1" colspan="2">21.7/126/294</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46,XY,t(9;12)(q34;p13)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Positive (P230)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Type B</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p>Published cases were reviewed by Gancheva et al [<xref rid="B5" ref-type="bibr">5</xref>].</p>
          <p><sup>*</sup>Values are presented in the International System of Units (WBC, &#xD7;10<sup>9</sup>/L; Hb, g/L; Platelet, &#xD7;10<sup>9</sup>/L).</p>
          <p>Abbreviations: CBC, complete blood count; WBC, white blood cell; F, female; M, male; NA, not available; RT-PCR, reverse transcription PCR.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
